Table 1 Trends in relative survival (%) by sex, time since diagnosis and calendar period of diagnosis: England and Wales, adults (15–99 years) diagnosed during 1986–1999 and followed up to 2001

From: Survival from cancers of the kidney and ureter in England and Wales up to 2001

  

Calendar period of diagnosis a

Average change (%)

Prediction c for patients

  

1986–1990

1991–1995

1996–1999

every 5 years b

diagnosed during 2000–2001

Time since diagnosis

 

Survival (%)

95% CI

Survival (%)

95% CI

Survival (%)

95% CI

Survival (%)

95% CI

Survival (%)

95% CI

1 year

Men

58.3

(57.2, 59.3)

60.9

(60.0, 61.9)

64.5

(63.5, 65.4)

2.6 **

(0.7, 4.6)

64.9

(63.5, 66.2)

 

Women

53.5

(52.1, 54.9)

56.2

(55.0, 57.4)

61.2

(60.0, 62.5)

3.0 *

(0.4, 5.5)

62.0

(60.2, 63.7)

5 years

Men

40.1

(38.9, 41.2)

42.8

(41.7, 43.8)

46.1

(44.8, 47.4)

4.5 **

(2.1, 6.8)

46.9

(45.3, 48.4)

 

Women

35.9

(34.5, 37.4)

39.7

(38.4, 41.0)

45.7

(44.1, 47.3)

3.7 *

(0.8, 6.7)

46.3

(44.3, 48.3)

10 years

Men

33.0

(31.8, 34.3)

35.6

(34.3, 37.0)

  

4.4

(−0.2, 9.0)

39.4

(37.6, 41.2)

 

Women

30.5

(29.0, 32.0)

35.4

(33.9, 36.9)

  

5.9 *

(0.4, 11.4)

41.9

(39.7, 44.1)

  1. CI=confidence interval.
  2. aSurvival estimated with cohort or complete approach (see Rachet et al, 2008).
  3. bMean absolute change (%) in survival every 5 years, adjusted for deprivation (see Rachet et al, 2008).
  4. cSurvival estimated with hybrid approach (see Rachet et al, 2008).
  5. *P<0.05; **P<0.01.
Back to article page